The global haemostasis and tissue sealing agents market is treading along a lucrative growth track in recent times. Advancements in wound-healing procedures have paved way for new opportunities within the global market. The presence of a well-performing healthcare industry has created room for market growth and maturity. Furthermore, healthcare professionals are focusing on the use of cutting-edge technologies that can aid treatment procedures. Henceforth, the global haemostasis and tissue sealing agents market is set to attract fresh opportunities in the years to follow. Use of high-quality materials for tissue sealing agents has proved to be a viable growth strategy for market players. Investments in medical research have helped in discovering new uses of sealing agents.

Surgical procedures have played an integral role in driving sales across the global haemostasis and tissue sealing agents market. Advancements in minimally invasive procedures have created new opportunities for growth across the market. The rising incidence of several chronic diseases that necessitate surgical treatments has become a launch pad for market growth. Medical practitioners and doctors consider it pivotal to use haemostats in order to control bleeding. Excessive bleeding can be extremely dangerous for people suffering from severe diseases and disorders. Hence, use of haemostasis and tissue sealing agents acts as a fool-proof precautionary measure within surgical treatments.

The global haemostasis and tissue sealing agents market is expected to grow at a stellar CAGR of 8% over the period between 2014 and 2020. The total volume of revenues within the global hemostasis and tissue sealing agents market is expected to touch by US$5.2 bn by 2020-end. This report preview by Transparency Market Research (TMR) throws light on several key factors pertaining to the growth of the global haemostasis and tissue sealing agents market. There is increasing demand for improved surgical procedures, and this is an important consideration for market growth.

Natural Tissue Sealants to Attract Increased Demand in thr Years to Follow

Based on the type of sealing agent, the global haemostasis and tissue sealing agents market can be segmented into natural tissue sealants, adhesion barrier products, and synthetic tissue sealants. The growing need for high-quality sealants that can accelerate the process of healing has given rise to the popularity of haemostasis and tissue sealing agents. There is increasing demand for organic sealants that do not have any side effects on the human body in the long run. This factor has also generated humongous growth opportunities within the market. Based on the type of haemostats, use of topical haemostats in gaining popularity in recent times. These haemostats are easy to use, and do not cause any discrepancies during surgery.

North America to Lead Market Growth

Based on regions, the global haemostasis and tissue sealing agents market can be segmented into Latin America, Europe, Asia Pacific, the Middle East and Africa, and North America. US and Canada have been at the forefront of advancements in healthcare, and these countries have exhibited a propensity towards medical innovation. For this reason, the North America haemostasis and tissue sealing agents market is set to attract voluminous revenues in the years to follow. Presence of trained medical practitioners and surgeons in the US has also generated new opportunities for market growth and advancement.

Some of the leading vendors operating in the global haemostasis and tissue sealing agents market are Johnson and Johnson, CryoLife, Inc., Advance Medical Solution Group plc, Pfizer, Inc., and Integra LifeSciences Corporation.

The hemostasis and tissue sealing agents market involves the study of wide range of hemostat, tissue sealant and adhesion barrier products which helps the surgeons to control bleeding during the surgery. These products play an important role in management of bleeding within the damaged blood vessels in surgical procedures. The market of hemostasis and tissue sealing agents is witnessing positive growth due to the introduction of technology advanced and cost effective hemostat and tissue sealing products by key companies. For example, in June 2013, Advance Medical Solution Group plc received approval for 2-octyl cyanoacrylate synthetic tissue adhesive. 
 
The company also offers wide range of hemostasis and tissue sealant products such as RESORBA, ActivHeal and LiquiBand. Thus, wide range of product offering will boost the uptake of these products hence drive the market growth. Other factors such as aging population and rising number surgical procedures further drive the growth of the hemostasis and tissue sealing agents market globally. For example, according to the World Health Organization (WHO), the number of people aged 65 years and above is expected to increase from 605 million to 2 billion by 2050. Aging population will boost the number of people undergoing surgical intervention which would in turn stimulate the demand of hemostat and tissue sealing agents. In addition, hemostat and tissue sealant products are still at a nascent stage in developing regions such as India and Latin America and expected to witness high growth rate in near future owing to the approval of new hemostat products by regulatory authorities. All these factors collectively fuel the revenues of hemostasis and tissue sealing agents market during the study period, hence boost market growth. However, strict regulatory policies coupled with high cost of the products will restrain the market growth worldwide.
 
This report encompasses a detailed study of various hemostat and tissue sealing agents. Hemostasis and tissue sealing agents market have been majorly segmented into types of products. This segment is categorized into two major type namely topical hemostats and adhesive and tissue sealant products. Topical hemostat products are further categorized into mechanical hemostat, active hemostat (i.e. thrombin based topical hemostat) and flowable hemostat (i.e. combinational topical hemostat). Hemostat products such as collagen, oxidized regenerated cellulose (ORC), gelatin and polysaccharide based topical hemostat are included under mechanical hemostat. 
 
Adhesive and tissue sealant are classified into natural tissue sealant, synthetic tissue sealant and adhesion barrier products. Natural tissue sealant comprises fibrin sealant and others (albumin and collagen based tissue sealant). Synthetic sealant includes cyanoacrylate based tissue sealant and others (polyethylene glycol and others). The market size and forecast for each type of products has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment.
 
Geographically, the global hemostasis and tissue sealing agents market has been segmented into four major regions namely North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each geography has been estimated for the period 2012 to 2020 in terms of revenue (USD million), considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) during the forecast period from 2014 to 2020 for all the geographies mentioned above.
 
The market overview section of the report discusses the market dynamics with respect to the market drivers, restraints and opportunities. This section also covers market attractiveness analysis and event impact analysis of the global hemostasis and tissue sealing agents market. Market share (%) of major players operating in the market has also been provided for the year 2013, followed by a list of recommendations for existing and new players to enter and enhance market share. The report concludes with company profiles of key players operating in various segments of the market. Each company profile includes business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the global hemostasis and tissue sealing agents market that have been profiled in the report include Johnson & Johnson Services, Inc., CryoLife, Inc., Baxter, Cohesion Technologies, C.R. Bard, Inc., Advance Medical Solution Group plc, Integra LifeScience, Pfizer, Inc. and others.
 
The Global Hemostasis and Tissue Sealing Agents market is segmented as follows:
  • Global Hemostasis and Tissue Sealing Agents Market, by Types of Products
    • Topical Hemostats
      • Mechanical Hemostats
        • Collagen based Topical Hemostats
        • Oxidized Regenerated Cellulose (ORC) based Topical Hemostats
        • Gelatin based Topical Hemostats
        • Polysaccharide based Topical Hemostat
      • Active Hemostats (Thrombin-Based Topical Hemostats)
      • Flowable Hemostats (Combination Topical Hemostats)
    • Adhesive and Tissue Sealing Agents
      • Natural Tissue Sealant
        • Fibrin Sealant
        • Other Natural Sealant (Albumin and Collagen based Tissue Sealant)
      • Synthetic Tissue Sealant
        • Cynoacrylate-Based Tissue Adhesives
        • Other Synthetic Tissue Sealant (Polyethylene Glycol and others)
      • Adhesion Barrier Products
  • Global Hemostasis and Tissue Sealing Agents Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Hemostasis Tissue Sealing Agents Market

Buy Now